NYSE:DLB - Dolby Laboratories Stock Price, News, & Analysis

Dolby Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "DLB."

Dolby Laboratories announced a quarterly dividend on Thursday, July 26th. Shareholders of record on Monday, August 6th will be paid a dividend of $0.16 per share on Tuesday, August 14th. This represents a $0.64 dividend on an annualized basis and a yield of 0.93%. The ex-dividend date of this dividend is Friday, August 3rd. View Dolby Laboratories' Dividend History.

Dolby Laboratories announced that its board has initiated a stock repurchase program on Sunday, April 9th 2017, which authorizes the company to repurchase $200,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase up to 3.9% of its stock through open market purchases. Stock repurchase programs are often an indication that the company's board believes its stock is undervalued.

Dolby Laboratories, Inc. (NYSE:DLB) released its earnings results on Wednesday, July, 25th. The electronics maker reported $0.92 earnings per share for the quarter, beating the consensus estimate of $0.69 by $0.23. The electronics maker earned $317.45 million during the quarter, compared to analyst estimates of $317.65 million. Dolby Laboratories had a net margin of 8.18% and a return on equity of 12.95%. Dolby Laboratories's quarterly revenue was up 3.9% on a year-over-year basis. During the same period last year, the business posted $0.73 earnings per share. View Dolby Laboratories' Earnings History.

Dolby Laboratories is scheduled to release their next quarterly earnings announcement on Wednesday, October, 24th 2018. View Earnings Estimates for Dolby Laboratories.

Dolby Laboratories issued an update on its fourth quarter earnings guidance on Wednesday, July, 25th. The company provided EPS guidance of $0.40-0.46 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.43. The company issued revenue guidance of $265-275 million, compared to the consensus revenue estimate of $271.27 million.

5 brokers have issued 12 month price objectives for Dolby Laboratories' shares. Their forecasts range from $52.00 to $78.00. On average, they anticipate Dolby Laboratories' share price to reach $66.40 in the next twelve months. This suggests that the stock has a possible downside of 3.3%. View Analyst Price Targets for Dolby Laboratories.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Dolby Laboratories in the last year. There are currently 3 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Dolby Laboratories.

Some companies that are related to Dolby Laboratories include InterDigital (IDCC), TiVo (TIVO), RPX (RPXC), Acacia Research (ACTG), Quarterhill (QTRH), Joint (JYNT), Liberty Tax (TAX), Digital Turbine (APPS), Finjan (FNJN), ITUS (ITUS), MGT Capital Investments (MGTI), XCel Brands (XELB), Research Frontiers (REFR), Marathon Patent Group (MARA) and ARC Group (ARCK).

News articles about DLB stock have been trending somewhat positive recently, Accern Sentiment reports. The research group identifies positive and negative media coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Dolby Laboratories earned a coverage optimism score of 0.20 on Accern's scale. They also assigned headlines about the electronics maker an impact score of 47.42 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the next several days. View Recent Headlines for Dolby Laboratories.

Dolby Laboratories' stock is owned by a variety of of institutional and retail investors. Top institutional investors include DOLBY DAGMAR (41.00%), DOLBY DAGMAR (40.60%), Janus Henderson Group PLC (3.65%), BlackRock Inc. (2.50%), FMR LLC (2.38%) and Renaissance Technologies LLC (2.16%). Company insiders that own Dolby Laboratories stock include Bob Borchers, Dagmar Dolby, Giles Baker, Kevin J Yeaman, Lewis Chew, Mark Andrew Sherman, N William Jasper, Jr, Nicholas Donatiello Jr, Nicholas Donatiello, Jr, Peter C Gotcher and Steven E Forshay. View Institutional Ownership Trends for Dolby Laboratories.

DLB stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., American Century Companies Inc., Quantum Capital Management, Baillie Gifford & Co., Renaissance Technologies LLC, River Road Asset Management LLC, Burney Co. and Fuller & Thaler Asset Management Inc.. Company insiders that have sold Dolby Laboratories company stock in the last year include Bob Borchers, Dagmar Dolby, Giles Baker, Kevin J Yeaman, Lewis Chew, Mark Andrew Sherman, N William Jasper, Jr, Nicholas Donatiello Jr, Peter C Gotcher and Steven E Forshay. View Insider Buying and Selling for Dolby Laboratories.

DLB stock was purchased by a variety of institutional investors in the last quarter, including Disciplined Growth Investors Inc. MN, Janus Henderson Group PLC, FMR LLC, Bank of Montreal Can, Nantahala Capital Management LLC, Millennium Management LLC, Bradley Foster & Sargent Inc. CT and Wells Fargo & Company MN. View Insider Buying and Selling for Dolby Laboratories.

Shares of DLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of DLB stock can currently be purchased for approximately $68.68.

Dolby Laboratories has a market capitalization of $7.15 billion and generates $1.08 billion in revenue each year. The electronics maker earns $201.80 million in net income (profit) each year or $2.20 on an earnings per share basis. Dolby Laboratories employs 2,122 workers across the globe.

Dolby Laboratories' mailing address is 1275 MARKET STREET, SAN FRANCISCO CA, 94103. The electronics maker can be reached via phone at 415-558-0200 or via email at [email protected]